Is doxycycline a powerful antibiotic for the coronavirus?

 Other factors that contribute to the widespread and disproportionate use of antibiotics are likely fear and insecurity surrounding the pandemic and the lack of internationally recognized antiviral agents with known efficacy. Although the acute prevalence of bacterial superinfection in CoVID19 is unknown, in certain studies with initial coinfections or secondary bacterial pneumonia in up to 35% of cases, reasonable and fair arguments for antibiotic therapy appear to be seen in COVID patients . 19 based on familiarity with bacterial superinfections in influenza.

Rationalizing the use of antibiotics The solution can be considered, while many needs for failed studies are expected to categorize and simplify the use of antibiotics in COVID-19 patients. Patients with the worst presentations should be reserved for antibiotics (eg, those with high oxygen demands and rapidly progressing respiratory failure).